Cargando…
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
OBJECTIVE: To determine whether plasma levels of advanced glycation end products and oxidation products play a role in the development of atherosclerosis in patients with type 2 diabetes (T2D) over nearly 10 years of the VA Diabetes Trial and Follow-up Study. RESEARCH DESIGN AND METHODS: Baseline pl...
Autores principales: | Saremi, Aramesh, Howell, Scott, Schwenke, Dawn C., Bahn, Gideon, Beisswenger, Paul J., Reaven, Peter D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360279/ https://www.ncbi.nlm.nih.gov/pubmed/28148544 http://dx.doi.org/10.2337/dc16-1875 |
Ejemplares similares
-
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018) -
Insulin Resistance and Hyperinsulinemia: You can't have one without the other
por: Kim, Sun H., et al.
Publicado: (2008) -
Diabetes, Atherosclerosis, and Stenosis by AI
por: Jonas, Rebecca A., et al.
Publicado: (2023) -
Progression of Vascular Calcification Is Increased With Statin Use in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2012) -
Association of Acculturation Levels and Prevalence of Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Kandula, Namratha R., et al.
Publicado: (2008)